RE:RE:pan can protocols
Hello CanadaFan,,,,I was kinda extrapolating from the pan can pr which states
Oncolytics expects to finalize the definitive agreements within the next 90 days and open the Precision Promise investigational treatment of pelareorep, checkpoint inhibitor, gemcitabine, and nab-paclitaxel in early 2024.
My point is that I expect early 2024 to be most likely 1st quarter 2024 which to onc is early and that is why I stated up to 6 months from the 90 days.
Everyone makes assumptions on this board and mine was just a generalization from onc past history and did not think that 1st quarter 2024 was out of line.
Hopefully it will be earlier and hopefully we will know within the 90 days although Matt did say at the quarterly cc.....
Our plan for this indication is to finalize agreements with the Precision Promise team by the fourth quarter of this year, and we expect to open the investigational treatment of pela a checkpoint inhibitor gemcitabine and nab-paclitaxel in early 2024..